Plasma endothelial microvesicles and their carrying miRNA‐155 serve as biomarkers for ischemic stroke
- 29 July 2020
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 98 (11) , 2290-2301
Abstract
Endothelial microvesicles (EMVs) could reflect the status of endothelial cells (ECs) which are involved in the pathogenesis of ischemic stroke (IS). MiR‐155 could regulate EC functions. However, their roles in IS remain unclear. This study aimed to investigate the levels of plasma EMVs and EMVs carrying miRNA‐155 (EMVs‐miR‐155) in IS patients to explore their potential roles as biomarkers. Ninety‐three IS patients and 70 controls were recruited in this study. The levels of circulating EMVs and EMVs‐miR‐155 were detected by fluorescence nanoparticle tracking analysis and quantitative real‐time PCR, respectively. The correlations between level of EMVs/EMVs‐miR‐155 and the onset time, severity, infarct volume, and subtypes of IS were analyzed. The severity and infarct volume were assessed by NIHSS and magnetic resonance imaging, respectively. Multivariate logistic regression analysis was used to investigate the risk factors of IS. The ROC curve and area under ROC curve (AUC) of EMVs and EMVs‐miR‐155 were determined. The levels of plasma EMVs and EMVs‐miR‐155 were increased significantly in acute and subacute stages of IS and remained unchanged in chronic stage, and were positively related to the infarct volume and NIHSS scores and were associated with large artery atherosclerosis and cardioembolism subtypes defined by Trial of Org 10 172 in acute stroke treatment (TOAST) classification. Multivariate logistic regression analysis demonstrated that plasma EMVs and EMVs‐miR‐155 were significant and independent risk factors of IS and their AUC were 0.778 and 0.851, respectively, and increased to 0.892 after combination. Our study suggests that plasma EMVs and EMVs‐miR‐155 are promising biomarkers for IS. The diagnostic value of EMVs‐miR‐155 is higher and their combination is the best.Keywords
Funding Information
- National Natural Science Foundation of China (81770500, 81870580)
This publication has 53 references indexed in Scilit:
- Intercellular Transport of MicroRNAsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Differences of Circulating Inflammatory Markers between Large- and Small Vessel Disease in Patients with Acute Ischemic StrokeInternational Journal of Medical Sciences, 2013
- Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide SynthaseHypertension, 2012
- Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 DiabetesThe Journal of Clinical Hypertension, 2012
- Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volumeJournal of Neurology, 2011
- An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive ratsJournal of Neuroscience Research, 2010
- Endothelial Dysfunction, Vascular Disease and Stroke: The ARTICO StudyCerebrovascular Diseases, 2009
- Caspase-3 is related to infarct growth after human ischemic strokeNeuroscience Letters, 2008
- Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcomeJournal of Thrombosis and Haemostasis, 2006
- Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats.Stroke, 1993